Outcomes for regulated enterprises.
Validra reads the commercial signals your systems already produce — contracts, billing, ledger — and turns them into defensible actions: recover revenue, stop waste, create growth.
Five commercial outcomes. One standard of proof.
Each engine acts on a different part of the enterprise; together they cover its full commercial life.
Transformation Cost Control
Stop waste before it reaches the ledger.
Surfaces scope drift, duplicated tooling and vendors billing for effort rather than outcomes — with the evidence to act.
Bill What You Sell
Recover earned revenue with contract-grade proof.
Closes the gap between contracts and billing systems, with audit-grade evidence behind every recovery.
New Revenue Creation
New revenue from customers you already serve.
Identifies credible new offerings from real commercial signals — evidence, not guesswork.
Adjustment Layer
Course-correct before small gaps get expensive.
Watches where commercial intent and operational reality drift apart and recommends the smallest defensible correction.
Evolution Layer
Be ready for the next version of your market.
Reads structural change early — pricing shifts, regulatory pressure, channel collapse.
Signals enterprises already produce.
Each resolves into a defensible recommendation with evidence to support it.
Billing vs contract drift
Revenue earned but not billed correctly.
Unbilled entitlements
Services delivered but not invoiced.
Transformation spend without outcome
Programmes spending without delivering savings.
Latent revenue in served customers
New offerings credible with existing customers.
Vendor effort decoupled from delivery
Suppliers billing for effort, not outcomes.
Pricing exposure under regulatory change
Commercial terms at risk from regulatory shifts.
Defensible, auditable, reversible.
Built into the platform, not retrofitted around it.
Defensible
Every recommendation cites the source records it stands on. No black-box outputs reach the boardroom.
Auditable
Every action leaves a trail a regulator, internal audit or external counsel could follow without translation.
Reversible
No commercial action ships without a stop-condition. If reality moves, the recommendation withdraws itself.
Above the dashboard. Below the decision.
It does not replace dashboards or BI — it produces what they cannot: a defensible commercial action.
Contracts · Billing · Ledger · Programme finance · Customer records
Recover · Stop · Reprice · Withdraw · Evolve
What a Validra finding looks like.
Illustrative, anonymised example. Every finding follows this structure.
Signal
A contracted service entitlement shows active in delivery records for 14 months, with no matching billing line.
Evidence
The finding cites the contract clause, delivery records and billing extract — every record source-linked.
Recommendation
Recover the unbilled amount under existing contract terms, drafted for commercial and legal teams to act on.
Stop-condition
If the records change — a credit note, variation or dispute — the recommendation withdraws itself and says why.
From first conversation to commercial outcome.
Pilots are structured so the evidence is tested before the commitment is made.
Scope
A defined commercial question, set of records and period. No open-ended access.
Read
Read-only, role-segregated access to your systems of record. Nothing is changed.
Evidence
Findings with the full evidence trail. Your teams can challenge every line before acting.
Outcome
Commercial terms tied to validated outcomes. If findings don't stand up, neither does the fee.
The non-negotiables, handled.
UK data residency
Records processed and retained inside UK boundaries.
Role-segregated access
Read, recommend and act are separable roles by default.
Evidence retention
Supporting records held under your retention policy.
Change-controlled deployments
Versioned releases, rollback paths, no silent updates.
Validra is currently in structured pilot engagements in telecommunications and financial services. Early findings are shared under confidentiality with qualified prospects.
Before the second meeting.
Evaluating Validra for a commercial challenge?
Request a pilot summary relevant to your sector.